Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo-Reference-Cited by-同舟云学术

Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo

Published:2011-12 Issue:1 Volume:312 Page:117-127
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Park Hyun-Joo,Kim Su-Ryun,Kim Mi-Kyoung,Choi Kyu-Sil,Jang Hye-Ock,Yun Il,Bae Soo-Kyung,Bae Moon-Kyoung

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Neuropeptides as growth factors for normal and cancerous cells;Rozengurt;Trends. Endocrinol. Metab.,2002

2. Autocrine and paracrine signaling through neuropeptide receptors in human cancer;Heasley;Oncogene,2001

3. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy;Cornelio;Ann. Oncol.,2007

4. [D-Arg1, D-Trp5, 7, 9, Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells;Seckl;Cancer Res.,1997

5. Development and function of bombesin-like peptides and their receptors;Ohki-Hamazaki;Int. J. Dev. Biol.,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspase‐driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications;Cell Biochemistry and Function;2024-02-13

2. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas;Pituitary;2023-08-29

3. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas;2023-07-03

4. Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma;Frontiers in Bioscience-Landmark;2023-03-16

5. Effect of NMB-regulated ERK1/2 and p65 signaling pathway on proliferation and apoptosis of cervical cancer;Pathology - Research and Practice;2022-10